653.3500 18.60 (2.93%)
NSE May 05, 2025 10:08 AM
Volume: 54,994
 

653.35
2.93%
Geojit BNP Paribas
We upgrade our rating to Accumulate based on 10x FY22 EPS with a target of price of Rs.485 as new launches in U.S and other regulated markets will drive growth. Revenues were down 26% yoy and down 16% qoq mainly on...
Number of FII/FPI investors decreased from 283 to 268 in Mar 2025 qtr
More from Strides Pharma Science Ltd.
Recommended